Radiation and Dual-Drug attack on tough liver tumors
NCT ID NCT07128355
Summary
This early-stage study is testing whether combining two immunotherapy drugs (botensilimab and balstilimab) with targeted radiation can help control a specific type of advanced colorectal cancer that has spread to the liver. It is for patients whose cancer has not responded well to standard chemotherapy. The main goal is to first check if this combination is safe and manageable, while also seeing if it can shrink tumors in the liver and elsewhere in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-MSI-H OR PMMR COLORECTAL CANCER WITH LIVER METASTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.